tiprankstipranks
Trending News
More News >
BioMarin Pharmaceutical (DE:BM8)
FRANKFURT:BM8

BioMarin Pharmaceutical (BM8) Revenue

Compare
1 Followers

BioMarin Pharmaceutical Revenue

BioMarin Pharmaceutical had a revenue of 874.57M in the quarter ending Dec 31, 2025, with 12.68%. This bring the company's revenue in the last twelve months to 3.22B, Decreased 4.11%. In the fiscal year ending Dec 31, 2025, BioMarin Pharmaceutical had annual revenue of 3.22B with 12.87% growth.
Revenue (ttm)
3.22B
Revenue Growth
P/S Ratio
3.05
Revenue/Employee
€1,059,623
Employees
3,040
Market Cap
€9.83B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
3.22B367.34M+12.87%
Dec 31, 2024
2.85B434.69M+17.97%
Dec 31, 2023
2.42B323.19M+15.42%
Dec 31, 2022
2.10B249.76M+13.53%
Dec 31, 2021
1.85B-14.18M-0.76%
Dec 31, 2020
1.86B156.41M+9.18%
Dec 31, 2019
1.70B212.79M+14.27%
Dec 31, 2018
1.49B177.61M+13.52%
Dec 31, 2017
1.31B